High-dose folinic acid (HDFA) combined with 5-fluorouracil (5-FU) in first line chemotherapy of advanced large bowel cancer
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (9) , 1303-1306
- https://doi.org/10.1016/0277-5379(87)90112-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Analysis of survival by tumor response.Journal of Clinical Oncology, 1986
- Guidelines for Reporting Clinical TrialsJournal of Clinical Oncology, 1986
- The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherolEuropean Journal of Cancer and Clinical Oncology, 1982
- Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetasePharmacology & Therapeutics, 1981
- Natural history of patients with untreated liver metastases from colorectal cancerThe American Journal of Surgery, 1981
- Reporting results of cancer treatmentCancer, 1981
- Perspectives on the design and biochemical pharmacology of inhibitors of thymidylate synthetaseJournal of Medicinal Chemistry, 1980
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomyCancer, 1969
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958